當(dāng)前位置：   首頁(yè) > 需求大廳

需求名稱(chēng)：黃體酮軟膠囊注冊(cè)標(biāo)準(zhǔn)JX20210003具體要求：Cyndea Pharma, S.L公司的黃體酮軟膠囊的注冊(cè)標(biāo)準(zhǔn)要求時(shí)間：請(qǐng)?jiān)?022年3月之前交稿方式：直接點(diǎn)擊交稿在線(xiàn)交稿就是了，我會(huì)每天過(guò)來(lái)看的，謝謝各位藥智的戰(zhàn)友們   [更多]

《中華人民共和國(guó)臨床用藥須知》（2020年版）資料信息，最好是PDF電子版內(nèi)容完整清晰，不得漏頁(yè)，少頁(yè)不得有亂碼   [更多]

文獻(xiàn)名稱(chēng): 1.A Systematic Review and Meta-analysis of Efficacy and Safety of Novel Interleukin Inhibitors in the Management of Psoriatic Arthritis. J Clin Rheumatol. 2017 Sep 19. 2.A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis.Immunotherapy. 2017 Sep;9(12):963-978 備注 : 將符合要求的文獻(xiàn)PDF格式上傳   [更多]

DrugsoftheFuture（DOF）2020年11-12期 文獻(xiàn)必須完整、準(zhǔn)確   [更多]

需求名稱(chēng)：西甲硅油質(zhì)量標(biāo)準(zhǔn) 具體要求：注冊(cè)標(biāo)準(zhǔn)號(hào)：JX201402333   [更多]

①文獻(xiàn)和網(wǎng)站來(lái)源必須權(quán)威、專(zhuān)業(yè)，盡量找外文或官網(wǎng)的文獻(xiàn)或報(bào)道，不能是百度百科等；②簡(jiǎn)要概述的語(yǔ)句具有邏輯性和連貫性。 ③由于藥物本身存在信息不全或難找到信息源，以及藥物概述質(zhì)量不定（如翻譯質(zhì)量不定等）的情況，賞金酌情給出，請(qǐng)諒解。 ④單價(jià)8元/條，質(zhì)量偏低需折價(jià)計(jì)算。 20個(gè)合格，2個(gè)內(nèi)容偏少，20*8+2*4=168*此任務(wù)金額為不含稅金額，按照國(guó)家稅務(wù)相關(guān)法律法規(guī)，提現(xiàn)時(shí)個(gè)稅由藥智匯代扣代繳   [更多]

質(zhì)量，最新版   [更多]

標(biāo)題： 1、Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial 2、Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice: results from the STRONG prospective, observational, multicenter study 3、Bioequivalence study of two perindopril erbumine tablet formulations in healthy volunteers 4、Development and in vitro/in vivo evaluation of immediate release perindopril tablets 5、The advantages of combination therapy on hypertension: development of immediate release perindoprilindapamide tablet and assessment of bioequivalence studies 6、Does Chinese ethnicity affect the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors? - PubMed - NCBI 7、Drug Dev Ind Pharm. 2013 Jul;39(7):996-1004. doi: 10.3109/03639045.2012.689765. Epub 2012 May 25. A potent preparation method combining neutralization with microfluidization for rebamipide nanosuspensions and its in vivo evaluation. Shi Y1, Zou M, An Y, Ji Z, Gao P, Cheng G. 8、Drug Dev Ind Pharm. 2006 Jul;32(6):651-60. Production of an extremly low dose procaterol HCl preparation by fluidized-bed coating method: in vitro and in vivo evaluation. Yu TW1, Chen RR, Gau CS. 9、Enhancement of solubility and dissolution of cilostazol by solid dispersion technique. Park JH, Choi HK. Arch Pharm Res. 2015 Jul;38(7):1336-44. doi: 10.1007/s12272-014-0547-6. Epub 2015 Jan 8. 10、Solid-state amorphization of rebamipide and investigation on solubility and stability of the amorphous form. Xiong X, Xu K, Li S, Tang P, Xiao Y, Li H. Drug Dev Ind Pharm. 2017 Feb;43(2):283-292. doi: 10.1080/03639045.2016.1239627. Epub 2016 Oct 6. 要求：將符合要求的文獻(xiàn)PDF格式打包上傳   [更多]

求購(gòu)2021罌粟乙碘油注射液所有的說(shuō)明書(shū)   [更多]

注射用頭孢呋辛鈉（西力欣?）質(zhì)量標(biāo)準(zhǔn)   [更多]